CD19 and neoplasm: Inducible systems (e.g., NFAT‐regulated IL‐12) improve safety,144, 145 and CD19‐CAR/IL‐12 T cells achieved tumour clearance and resistance to Treg‐mediated suppression in syngeneic settings.146